Atlas Trials

Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients

Clinical trial NCT03331601 · TERMINATED

Trial details

NCT number
NCT03331601
Sponsor
Universitair Ziekenhuis Brussel
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
CarcinomaReceptor, ErbB-2
Start date
2017-10-16
Primary completion
2025-10-14
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.